Hepatitis C Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Hepatitis C
- People who are currently experiencing homelessness without shelter (such as sleeping outside or in places not meant for housing) at the time the study begins
- People who speak English or Spanish
- People who are receiving care through a street medicine program (medical care provided directly to people experiencing homelessness in outdoor or community settings)
- People whose Hepatitis C condition meets a specific set of treatment guidelines set by a major liver disease medical organisation, meaning their case is considered straightforward enough for a simplified treatment approach (confirm with trial site)
Who may not be able to join:
- People who have previously received treatment for Hepatitis C
- People who have a serious form of liver scarring called decompensated cirrhosis, or who test positive for Hepatitis B surface antigen (a marker indicating active Hepatitis B infection)
- People who are currently pregnant, or who have been diagnosed with or are suspected of having liver cancer (hepatocellular carcinoma)
- People who have previously had a liver transplant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Camilo Zaks, MD, University of Southern California, Keck School of Medicine of USC, Department of Family Medicine, USC Street Medicine
Phone: 626-457-4207
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Medication Adherence Rate; Length of treatment course
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.